SC

STEPHEN CONAFAY

THE CONAFAY GROUP, LLC · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
2
last 3 years
Filings
6
6 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY25 Appropriations and PAHPA.
Health Issues · 2024 Q4
Legislation related to antimicrobial resistance(AMR), reimbursement reform, the PASTEUR Act, Cares Act 2.0 and FY25 Appropriations and PAHPA.
Health Issues · 2024 Q3
Support for medical/disease research.
Medical/Disease Research/Clinical Labs · 2024 Q2
Legislation related to antimicrobial resistance(AMR), reimbursement reform, the PASTEUR Act, Cares Act 2.0 and FY24 Appropriations and PAHPA.
Health Issues · 2024 Q2

Clients

$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q4
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
Q4lda.gov →
2024 Q3
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
Q3lda.gov →
2024 Q2
ATEA PHARMACEUTICALS, INC.
Q2lda.gov →
2024 Q2
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
Q2lda.gov →
2024 Q1
ATEA PHARMACEUTICALS, INC.
Q1lda.gov →
2024 Q1
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
Q1lda.gov →
Showing recent filings · full history on lda.gov